論文

2021年4月

Drug-eluting stent thrombosis: current and future perspectives.

Cardiovascular intervention and therapeutics
  • Shoichi Kuramitsu
  • ,
  • Shinjo Sonoda
  • ,
  • Kenji Ando
  • ,
  • Hiromasa Otake
  • ,
  • Masahiro Natsuaki
  • ,
  • Reo Anai
  • ,
  • Yasuhiro Honda
  • ,
  • Kazushige Kadota
  • ,
  • Yoshio Kobayashi
  • ,
  • Takeshi Kimura

36
2
開始ページ
158
終了ページ
168
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1007/s12928-021-00754-x

Over the past 40 years, the safety and efficacy of percutaneous coronary intervention has dramatically improved by overcoming several challenges. The introduction of drug-eluting stent (DES) in particular was a major breakthrough in interventional cardiology. Compared to bare-metal stents, first-generation DES (G1-DES) has dramatically reduced the rates of in-stent restenosis and subsequent target lesion revascularization. However, major safety concerns surrounding stent thrombosis (ST) emerged with G1-DES in clinical practice as a result of the high incidences of death, myocardial infarction, and repeat revascularization associated with ST. To overcome these limitations, second-generation DES (G2-DES) has been developed with an improved stent platform with thinner strut and biocompatible durable or biodegradable polymers. Indeed, G2-DES, when compared with G1-DES, has improved clinical outcomes by reducing the risk of late thrombotic events while maintaining anti-restenotic efficacy, whereas ST still occurs, even with the use of G2-DES. This review gives an overview of pathophysiology, risk factors, and outcomes of ST after DES implantation. Additionally, we discuss the management and prevention of ST.

リンク情報
DOI
https://doi.org/10.1007/s12928-021-00754-x
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/33439454
ID情報
  • DOI : 10.1007/s12928-021-00754-x
  • PubMed ID : 33439454

エクスポート
BibTeX RIS